Do we have evidence that something fundamental has changed in our knowledge about PCa screening? PCa is the second most frequently diagnosed type of cancer worldwide and the sixth leading cause of cancer deaths in men. In Germany, it is the most commonly diagnosed cancer and the third leading...
They commented that:"The real impact and tragedy of prostate cancer screening is the doubling of the lifetime risk of a diagnosis of prostate cancer with little if any decrease in the risk of dying from this disease."In 1985, before PSA was used in the US, an American man's lifetime ...
Up to date, screening for prostate cancer (PCa) remains one of the most appealing but also a very controversial topics in the urological community. PCa is the second most common cancer in men worldwide and it is universally acknowledged as a complex disease, with a multi-factorial etiology. ...
This exploratory study examined factors and decisional balance (DB) that influence participation in prostate cancer (PCa) screening in Saudi Arabia. The secondary purpose of the study is to develop the groundwork for future interventions to support at-risk men, to develop the health habit of getti...
The PLCO interim results show that prostate cancer screening leads to more diagnoses of the disease, but does not appear to affect prostate-cancer-related mortality. At 7 years, screening was associated with a relative increase of 22% in the rate of prostate cancer diagnosis, compared with a ...
New research led by investigators from Weill Cornell Medicine, Fred Hutchinson Cancer Center, University Hospitals Cleveland and Case Western Reserve University found that prostate cancer screening with the prostate specific antigen (PSA) blood test has
After differences in implementation and settings were accounted for, two important prostate cancer screening trials provide compatible evidence that screening reduces prostate cancer mortality. These findings suggest that current guidelines recommending
Prostate cancer screening (PCS) is controversial. Ideally, patients should understand the risks and benefits of screening before undergoing PSA testing. This study assessed whether primary care physicians routinely discuss PCS and explored the barriers to and facilitators of these discussions. METHODS Qual...
Benefits and Harms of Prostate-Specific Antigen Screening for Prostate Cancer: An Evidence Update for the U.S. Preventive Services Task Force BACKGROUND: is the most common nonskin in men in the United States, and screening has increased in recent years. In 2002, the U.S. Preventive ...
National Collaborating Centre for Cancer, PCa: diagnosis and treatment [29]National Institute for Health and Care Excellence, 2014NoGive men information, support and adequate time to make a decision. Include explanation of the risks and benefits of screening ...